These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26350938)

  • 1. Validity and Reliability of the Japanese Version of the Rome III Diagnostic Questionnaire for Irritable Bowel Syndrome and Functional Dyspepsia.
    Kanazawa M; Nakajima S; Oshima T; Whitehead WE; Sperber AD; Palsson OS; Drossman DA; Miwa H; Fukudo S
    J Neurogastroenterol Motil; 2015 Oct; 21(4):537-44. PubMed ID: 26350938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of the Malay-language translation of the Rome III Diagnostic Questionnaire for irritable bowel syndrome.
    Lee YY; Waid A; Tan HJ; Chua SB; Whitehead WE
    J Gastroenterol Hepatol; 2012 Apr; 27(4):746-50. PubMed ID: 22004172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and Validation of Enhanced Asian Rome III Questionnaires in Bengali Language for Diagnosis of Functional Gastrointestinal Disorders.
    Rahman MM; Ghoshal UC; Rowshon AH; Ahmed F; Kibria MG; Hasan M; Gwee KA; Whitehead WE
    J Neurogastroenterol Motil; 2016 Apr; 22(2):240-7. PubMed ID: 26690730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Japanese version of the Rome II modular questionnaire and irritable bowel syndrome severity index.
    Shinozaki M; Kanazawa M; Sagami Y; Endo Y; Hongo M; Drossman DA; Whitehead WE; Fukudo S
    J Gastroenterol; 2006 May; 41(5):491-4. PubMed ID: 16799892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of combination of functional dyspepsia and irritable bowel syndrome: a meta-analysis of studies using the Rome III-IV Criteria].
    Andreev DN; Bordin DS; Vyuchnova ES; Lebedeva EG; Dicheva DT; Umyarova RM; Maev IV
    Ter Arkh; 2022 Oct; 94(9):1099-1108. PubMed ID: 36286762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of pediatric functional gastrointestinal disorders related to abdominal pain using Rome III vs. Rome IV criterions.
    Edwards T; Friesen C; Schurman JV
    BMC Gastroenterol; 2018 Mar; 18(1):41. PubMed ID: 29549882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Schurman JV; Karazsia BT; Friesen CA
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
    von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
    Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J).
    Kanazawa M; Drossman DA; Shinozaki M; Sagami Y; Endo Y; Palsson OS; Hongo M; Whitehead WE; Fukudo S
    Biopsychosoc Med; 2007 Mar; 1():6. PubMed ID: 17371576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia.
    Hammer J; Eslick GD; Howell SC; Altiparmak E; Talley NJ
    Gut; 2004 May; 53(5):666-72. PubMed ID: 15082584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome.
    Talley NJ; Holtmann G; Walker MM; Burns G; Potter M; Shah A; Jones M; Koloski NA; Keely S
    Clin Transl Gastroenterol; 2019 Jul; 10(7):e00064. PubMed ID: 31356481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence Survey of Functional Dyspepsia and Irritable Bowel Syndrome in Chinese College Students Based on Rome Ⅳ Diagnostic Criteria].
    Gao X; Liu N; Hao YJ; Zhang XH; Yang Q; Jiang XS; Liu YX; Cai YQ; Song P; Ji FP; Wang JH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):574-578. PubMed ID: 37248586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
    Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.